Medtronic 2013 Annual Report Download - page 138

Download and view the complete annual report

Please find page 138 of the 2013 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 145

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145

75732me_10K.indd 123 6/25/13 6:40 PM
Table of Contents
PART III
Item 10. Directors, Executive Officers, and Corporate Governance
The sections entitled “Proposal 1 Election of Directors Directors and Nominees,” “Governance of Medtronic Committees
of the Board and Meetings,” “Governance of Medtronic — Audit Committee,” “Governance of Medtronic — Audit Committee
Audit Committee Independence and Financial Experts,” “Governance of Medtronic Nominating and Corporate Governance
Committee,” and “Share Ownership Information Section 16(a) Beneficial Ownership Reporting Compliance” in our Proxy
Statement for our 2013 Annual Shareholders’ Meeting are incorporated herein by reference. See also “Executive Officers of
Medtronic” on pages 16 to 17 herein.
We have adopted a written Code of Ethics that applies to our Chief Executive Officer, Chief Financial Officer, Corporate Treasurer,
Corporate Controller, and other senior financial officers performing similar functions who are identified from time to time by the
Chief Executive Officer. We have also adopted a written Code of Business Conduct and Ethics for Members of the Board of
Directors. The Code of Ethics for Senior Financial Officers, which is part of our broader Code of Conduct applicable to all
employees, and the Code of Business Conduct and Ethics for Members of the Board of Directors are posted on our website,
www.medtronic.com under the “Investors” caption and then under the “Corporate Governance” subcaption. Any amendments to,
or waivers for executive officers or directors of, these ethics codes will be disclosed on our website promptly following the date
of such amendment or waiver.
Item 11. Executive Compensation
The sections entitled “Governance of Medtronic Director Compensation,” “Governance of Medtronic Compensation
Committee Compensation Committee Interlocks and Insider Participation,” “Compensation Discussion and Analysis (CD&A),”
and “Executive Compensation” in our Proxy Statement for our 2013 Annual Shareholders’ Meeting are incorporated herein by
reference. The section entitled “Compensation Committee Report” in our Proxy Statement for our 2013 Annual Shareholders’
Meeting is furnished herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
The sections entitled “Share Ownership Information Significant Shareholders,” “Share Ownership Information Beneficial
Ownership of Management,” and “Executive Compensation — Equity Compensation Plan Information” in our Proxy Statement
for our 2013 Annual Shareholders’ Meeting are incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The sections entitled “Proposal 1 Election of Directors — Director Independence” and “Proposal 1 Election of Directors
— Related Transactions and Other Matters” in our Proxy Statement for our 2013 Annual Shareholders’ Meeting are incorporated
herein by reference.
Item 14. Principal Accounting Fees and Services
The sections entitled “Governance of Medtronic Audit Committee — Audit Committee Pre-Approval Policies” and “Report
of the Audit Committee — Audit and Non-Audit Fees” in our Proxy Statement for our 2013 Annual Shareholders’ Meeting are
incorporated herein by reference.
120